Elevance Health Inc. (ELV)

683 Capital Management LLC trimmed its holdings in Elevance Health, Inc. (NYSE: ELV) by 7.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,000 shares of the company's stock after selling 2,000 shares during the period. 683 Capital Management LLC's holdings

INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are evolving to better support their members in a broader range of situations that affect health. In part.

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as most of its non-Blue-branded subsidiaries. In addition, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to “a+” (Excellent).

Federated Hermes Inc. reduced its holdings in shares of Elevance Health, Inc. (NYSE: ELV) by 6.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 26,602 shares of the company's stock after selling 1,872 shares during the period. Federated

Dearborn Partners LLC purchased a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,781 shares of the company's stock, valued at approximately $693,000. A number of other hedge funds and other

INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing bo.

Archon Partners LLC lowered its holdings in shares of Elevance Health, Inc. (NYSE: ELV) by 60.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,000 shares of the company's stock after selling 30,000 shares during the period. Archon

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield of New York today announced a donation of more than $60,000 to help fund more than 32 food distribution events in partnership with The Campaign Against Hunger (TCAH) and Food Bank for New York City. The initiative will provide an added lifeline to families struggling to make ends meet, especially during the holiday season when budgets are stretched and demand for food assistance rises.

Intel (INTC) rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel's x86 central processing units (CPUs) with Nvidia GPUs in AI server systems. Oracle (ORCL) (Information Technology, Systems Software) performed strongly on the continued follow-through following strong quarterly results. Elevance Health (ELV) (Health Care, Managed Health Care) has a high Corporate Resilience Score and is aligned to the Health Access and Innovation theme.

California Public Employees Retirement System lowered its position in shares of Elevance Health, Inc. (NYSE: ELV) by 7.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 538,983 shares of the company's stock after selling 44,369 shares during the period.

Callodine Capital Management LP bought a new stake in Elevance Health, Inc. (NYSE: ELV) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 19,000 shares of the company's stock, valued at approximately $7,390,000. A number of other institutional investors and

Edgestream Partners L.P. purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,154 shares of the company's stock, valued at approximately $1,227,000. Several other hedge funds

Guru Stock PicksJana Partners has made the following transactions:Reduce in MRCY by 16.66%Add in THS by 0.13%Stock News Netflix wins WBD studio deal: Netflix (N

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand their benefits, and find care with confidence. Available through the Sydney Health app and Elevance Health–affiliated health plan websites, Virtual Assistant uses conversational technology to simplify healthcare navigation and improve engagement between members and their health plans. “At Elevance Hea.

Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health

Elevance Health is rated a Buy with a $400 price target, reflecting 18% upside and potential market outperformance. ELV trades at a significant discount to peers, with an 11x earnings multiple and strong double-digit top-line growth despite sector headwinds. Recent FQ3 2025 results showed a double-beat, with revenue up 12% year-over-year and EPS surpassing analyst estimates, signaling a turnaround.